Abstract
Introduction: Covid-19 infection has caused numerous physiological effects on health, including sleep (Pakpour AH et al., 2020). Many aspects of sleep disturbances in Covid-19 patients have been studied (Carnes-Vendrell A et al., 2024). So far, quality of sleep has been analyzed the most (Munteanu I et al., 2023). This study aimed to investigate the impact of Covid-19 infection on sleep quality and excess daytime sleepiness in home-treated and hospital-treated patients.
Method: A questionnaire-based longitudinal cohort study was conducted enrolling home-treated and hospital-treated Covid-19 patients. Participants were assessed at 3 and 6 months after hospital discharge using internationally validated self-evaluation scales, including the Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Patients with previously diagnosed sleep disorders and those unable to comprehend questionnaires were excluded from the study. All data were analyzed using IBM SPSS Statistics 28.0.
Results: In total, 66 participants were enrolled in the study, predominantly females, 74.2% (n = 49). The mean age of this study population was 44.05 ± 21.61 years, and the majortiy of them were treated at the hospital, 54.4% (n = 36). At 3 months after hospital discharge, 36.1% (n = 13) of home-treated patients reported good quality of sleep, to compare with 80.0% (n = 24) of hospital-treated patients, p < 0.001. At 6 months after hospital discharge, the difference between good sleep quality among home-treated and hospital-treated patients remained satistically significant with 47.2% (n = 17) and 76.7% (n = 23) of patients reporting good sleep quality, respectively, p = 0.015. Among this study population, no significant difference was observed in excessive daytime sleepiness: ESS ≥ 11 was noted in 24.2% (n = 9) home-treated patients and in 6.6% (n = 2) hospital-treated patients, p = 0.215. At 6 months, ESS ≥11 was detected in 25.0% (n = 9) home-treated patients and in 6.7% (n = 2) hospital-treated patients, respectively, p = 0.163.
Conclusion: A significant associaton between sleep quality in home-treated and hospital-treated patients was detected. Excessive daytime sleepiness did not demonstrate a significant difference. This study marks the importance of addressing sleep disturbances, including sleep quality, among Covid-19 patients based on their treatment setting. Covid-19 patients require equal treatment strategies regardless of underlying settings to improve patient outcomes and overall well-being.
Method: A questionnaire-based longitudinal cohort study was conducted enrolling home-treated and hospital-treated Covid-19 patients. Participants were assessed at 3 and 6 months after hospital discharge using internationally validated self-evaluation scales, including the Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Patients with previously diagnosed sleep disorders and those unable to comprehend questionnaires were excluded from the study. All data were analyzed using IBM SPSS Statistics 28.0.
Results: In total, 66 participants were enrolled in the study, predominantly females, 74.2% (n = 49). The mean age of this study population was 44.05 ± 21.61 years, and the majortiy of them were treated at the hospital, 54.4% (n = 36). At 3 months after hospital discharge, 36.1% (n = 13) of home-treated patients reported good quality of sleep, to compare with 80.0% (n = 24) of hospital-treated patients, p < 0.001. At 6 months after hospital discharge, the difference between good sleep quality among home-treated and hospital-treated patients remained satistically significant with 47.2% (n = 17) and 76.7% (n = 23) of patients reporting good sleep quality, respectively, p = 0.015. Among this study population, no significant difference was observed in excessive daytime sleepiness: ESS ≥ 11 was noted in 24.2% (n = 9) home-treated patients and in 6.6% (n = 2) hospital-treated patients, p = 0.215. At 6 months, ESS ≥11 was detected in 25.0% (n = 9) home-treated patients and in 6.7% (n = 2) hospital-treated patients, respectively, p = 0.163.
Conclusion: A significant associaton between sleep quality in home-treated and hospital-treated patients was detected. Excessive daytime sleepiness did not demonstrate a significant difference. This study marks the importance of addressing sleep disturbances, including sleep quality, among Covid-19 patients based on their treatment setting. Covid-19 patients require equal treatment strategies regardless of underlying settings to improve patient outcomes and overall well-being.
| Original language | English |
|---|---|
| Article number | P233 |
| Journal | Journal of Sleep Research |
| Volume | 33 |
| Issue number | Suppl.1 |
| DOIs | |
| Publication status | Published - Sept 2024 |
| Event | 27th Congress of the European Sleep Research Society - Seville, Spain Duration: 24 Sept 2024 → 27 Sept 2024 Conference number: 27 https://esrs.eu/event/sleep-europe-2024/ |
Field of Science*
- 3.2 Clinical medicine
- 3.3 Health sciences
Publication Type*
- 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database